Trademark: 98107947
Word
NUVTEYMA
Status Date
Wednesday, January 17, 2024
Filing Date
Saturday, July 29, 2023
Published for Opposition
Tuesday, October 10, 2023
5 Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; Pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; Pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; Pharmaceutical preparations for the treatment and prevention of rhinitis; Pharmaceutical preparations for the treatment and prevention of Behcet's disease; Pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; Pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; Pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions; Pharmaceutical preparations for the treatment and prevention of chronic rhinosinusitis; Pharmaceutical preparations for the treatment and prevention of hidradenitis suppurativa; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of metastasis
The mark consists of "NUVTEYMA" followed by a design of overlapping spherical triangles.
Color is not claimed as a feature of the mark.
Jan 19, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 17, 2024
Sou Extension 1 Granted
Jan 17, 2024
Sou Extension 1 Filed
Jan 17, 2024
Sou Teas Extension Received
Dec 5, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 10, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 10, 2023
Published For Opposition
Sep 20, 2023
Notification Of Notice Of Publication E-Mailed
Sep 1, 2023
Approved For Pub - Principal Register
Aug 30, 2023
Assigned To Examiner
Aug 30, 2023
Notice Of Design Search Code E-Mailed
Aug 29, 2023
New Application Office Supplied Data Entered
Aug 2, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
